Trials / Completed
CompletedNCT02256839
Evaluation of the QuantiFERON-TB Test.
Evaluation of the 4th Generation QuantiFERON-TB Gold Test (CST001) for the Detection of Tuberculosis Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 268 (actual)
- Sponsor
- QIAGEN Gaithersburg, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Detailed description
To compare the specificity of the CST001 assay to the QFT Gold Test in low TB exposure risk subjects and non-tuberculosis mycobacterial infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CST_001 |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-10-06
- Last updated
- 2019-08-01
- Results posted
- 2019-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02256839. Inclusion in this directory is not an endorsement.